Skip to content

Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients

A Multimedia Self-management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03686007
Enrollment
380
Registered
2018-09-26
Start date
2018-11-06
Completion date
2026-12-14
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver, Stage IA Lung Cancer AJCC v7, Stage IB Lung Cancer AJCC v7, Stage IIA Lung Cancer AJCC v7, Stage IIB Lung Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v7, Stage IIIB Lung Cancer AJCC v7, Stage III Lung Cancer AJCC v7, Stage II Lung Cancer AJCC v7, Stage I Lung Cancer AJCC v7

Brief summary

This randomized phase III trial studies how well a multimedia self-management intervention works in preparing family caregivers and patients with stage I-III lung cancer for lung cancer surgery. The multimedia self-management intervention, Preparing for your Lung Cancer Surgery, is a nurse-led, caregiver-based, multimedia intervention that may improve patient recovery after surgery, lower caregiving burden, and improve distress and quality of life.

Detailed description

PRIMARY OBJECTIVES: I. Test the effects of the multimedia self-management (MSM) intervention on family caregivers (FCG) outcomes and cancer support services use at discharge and 3-month post-discharge, comparing intervention and attention control groups. II. Test the effects of the MSM intervention on patient outcomes and healthcare resource use at discharge and 3-months post-discharge, comparing intervention and attention control groups. III. Test the effects of the MSM intervention on outcome mediators at discharge and 3-months post-discharge, comparing intervention and attention control groups. SECONDARY OBJECTIVES: I. Explore moderators (age, sex, marital status, caregiver relationship to patient, caregiver employment status, co-morbidities) of FCG and patient outcomes and reciprocal relationships. II. Determine, through exit interviews, participant's experience with the MSM intervention. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support by telephone (separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. GROUP II: Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a clinical research associate (CRA) approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone calls at 2 and 7 days, and 2 months post-discharge.

Interventions

OTHERInformational Intervention

Receive MSM intervention handbook

OTHERMedia Intervention

View the MSM intervention videos

Sponsors

City of Hope Medical Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Family Caregiver Inclusion Criteria: * A family member or friend identified by the patient as being the primary care provider before and after surgery * A patient/care recipient enrolled in the study * Age 21 years or older * Able to read or understand English Patient Inclusion Criteria: * Diagnosis of Stage I-III non-small cell lung cancer * Scheduled to undergo surgery for treatment * A family caregiver enrolled in the study * Age 21 years or older * Able to read or understand English.

Design outcomes

Primary

MeasureTime frameDescription
Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean caregiver psychological distress scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in psychological distress between the intervention and control arm over time. Score range: 0-10. Higher score means worse outcome.
Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean caregiver burden scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in burden between the intervention and control arm over time. The model included treatment arm, time, and the interaction between treatment arm and time as effects. Total burden score is calculated by summing items from 3 subscales: objective burden, subjective burden \& demand burden. Score range: 14-70. Higher score means worse outcome.
Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)Outcomes are measured before surgery (baseline), 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean caregiver preparedness scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in preparedness between the intervention and control arm over time. Score range: 0-4. Higher score means better outcome.
Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean caregiver QoL scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in QoL between the intervention and control arm over time. Total QoL score is calculated by summing items from 3 subscales: physical well-being, psychological well-being, social concerns \& spiritual well-being. Score range: 0-40. Higher score means better outcome.
Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)Outcomes are measured at discharge, 1 month, and 3 months post-discharge.Differences in the number of caregivers who saw a support services specialist were compared between both groups using Chi-squared and Fisher's exact test.
Change in Patient Psychological Distress (as Measured by the Distress Thermometer)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean patient psychological distress scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in psychological distress between the intervention and control arm over time. Score range: 0-10. Higher score means worse outcome.
Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean patient QoL scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in QoL between the intervention and control arm over time. Total FACT-L score is calculated by summing items from 5 subscales: physical well-being, social/family well-being, emotional well-being, functional well-being \& lung cancer subscale. Score range: 0-136. Higher score means better outcome.
Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)Outcomes are measured at 1 month, and 3 months post-discharge.Differences in the number of patients who were readmitted to the hospital for an overnight stay were compared between both groups using Chi-squared and Fisher's exact test.

Secondary

MeasureTime frameDescription
Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean caregiver self-efficacy scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in self-efficacy between the intervention and control arm over time. Score range: 1-4. Higher score means better outcome.
Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean patient self-efficacy scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in self-efficacy between the intervention and control arm over time. Score range: 1-4. Higher score means better outcome.
Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean caregiver activation scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in activation between the intervention and control arm over time. Score range: 10-60. Higher score means better outcome.
Change in Patient Activation (as Measured by the Patient Activation Measure)Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.Mean patient activation scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in activation between the intervention and control arm over time. Score range: 0-100. Higher score means better outcome.
Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)Outcomes are measured at baseline, 1 month, and 3 months post-dischargeMean family caregiver knowledge scores from baseline to 3 months post-discharge were calculated. T-tests were used to assess differences in knowledge between the intervention and control arm at different timepoints. Score range: 0-10. Mean: 8.24 with a standard deviation of 1.19. Higher score means better outcome.
Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)Outcomes are measured at baseline, 1 month, and 3 months post-dischargeMean patient knowledge scores from baseline to 3 months post-discharge were calculated. T-tests were used to assess differences in knowledge between the intervention and control arm at different timepoints. Score range: 0-10. Mean: 8.42 with a standard deviation of 1.16. Higher score means better outcome.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORVirginia Sun, RN, PhD

City of Hope Medical Center

PRINCIPAL_INVESTIGATORJae Kim, MD

City of Hope Medical Center

Participant flow

Recruitment details

542 participants (342 patients, 200 caregivers) were assessed for study eligibility. After 162 participants were excluded for various reasons - not meeting inclusion criteria (n= 91), declined to participate (n= 48), other/unknown reasons (n= 3), late ineligibility (n= 20), 380 participants (190 dyads - 190 patients, 190 caregivers) were randomized.

Pre-assignment details

542 participants (342 patients, 200 caregivers) were assessed for study eligibility. After 162 participants were excluded for various reasons - not meeting inclusion criteria (n= 91), declined to participate (n= 48), other/unknown reasons (n= 3), late ineligibility (n= 20), 380 participants (190 dyads - 190 patients, 190 caregivers) were randomized.

Participants by arm

ArmCount
Group I (MSM Intervention)
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
188
Group II (Attention Control)
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on Clinical Trials), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
192
Total380

Baseline characteristics

CharacteristicGroup I (MSM Intervention)TotalGroup II (Attention Control)
Age, Continuous67.5 years66.0 years65.0 years
Ethnicity (NIH/OMB)
Hispanic or Latino
27 Participants48 Participants21 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
153 Participants319 Participants166 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
8 Participants13 Participants5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
42 Participants85 Participants43 Participants
Race (NIH/OMB)
Black or African American
4 Participants12 Participants8 Participants
Race (NIH/OMB)
More than one race
1 Participants7 Participants6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
13 Participants29 Participants16 Participants
Race (NIH/OMB)
White
126 Participants244 Participants118 Participants
Region of Enrollment
United States
188 participants380 participants192 participants
Sex: Female, Male
Female
110 Participants226 Participants116 Participants
Sex: Female, Male
Male
77 Participants153 Participants76 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 1880 / 192
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)

Mean caregiver burden scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in burden between the intervention and control arm over time. The model included treatment arm, time, and the interaction between treatment arm and time as effects. Total burden score is calculated by summing items from 3 subscales: objective burden, subjective burden & demand burden. Score range: 14-70. Higher score means worse outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)Baseline44.68 score on a scale
Group I (MSM Intervention)Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)1 month post-discharge42.19 score on a scale
Group I (MSM Intervention)Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)3 months post-discharge40.45 score on a scale
Group II (Attention Control)Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)Baseline44.56 score on a scale
Group II (Attention Control)Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)1 month post-discharge44.73 score on a scale
Group II (Attention Control)Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)3 months post-discharge42.00 score on a scale
Primary

Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)

Mean caregiver psychological distress scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in psychological distress between the intervention and control arm over time. Score range: 0-10. Higher score means worse outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)Baseline3.92 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)1 month post-discharge3.38 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)3 months post-discharge3.22 score on a scale
Group II (Attention Control)Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)Baseline4.19 score on a scale
Group II (Attention Control)Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)1 month post-discharge3.74 score on a scale
Group II (Attention Control)Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)3 months post-discharge4.14 score on a scale
Primary

Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)

Mean caregiver QoL scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in QoL between the intervention and control arm over time. Total QoL score is calculated by summing items from 3 subscales: physical well-being, psychological well-being, social concerns & spiritual well-being. Score range: 0-40. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)Baseline27.04 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)1 month post-discharge27.69 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)3 months post-discharge27.51 score on a scale
Group II (Attention Control)Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)Baseline26.83 score on a scale
Group II (Attention Control)Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)1 month post-discharge26.67 score on a scale
Group II (Attention Control)Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)3 months post-discharge26.43 score on a scale
Primary

Change in Patient Psychological Distress (as Measured by the Distress Thermometer)

Mean patient psychological distress scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in psychological distress between the intervention and control arm over time. Score range: 0-10. Higher score means worse outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Patient Psychological Distress (as Measured by the Distress Thermometer)Baseline4.23 score on a scale
Group I (MSM Intervention)Change in Patient Psychological Distress (as Measured by the Distress Thermometer)1 month post-discharge3.42 score on a scale
Group I (MSM Intervention)Change in Patient Psychological Distress (as Measured by the Distress Thermometer)3 months post-discharge3.25 score on a scale
Group II (Attention Control)Change in Patient Psychological Distress (as Measured by the Distress Thermometer)Baseline4.39 score on a scale
Group II (Attention Control)Change in Patient Psychological Distress (as Measured by the Distress Thermometer)1 month post-discharge3.55 score on a scale
Group II (Attention Control)Change in Patient Psychological Distress (as Measured by the Distress Thermometer)3 months post-discharge3.76 score on a scale
Primary

Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)

Mean patient QoL scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in QoL between the intervention and control arm over time. Total FACT-L score is calculated by summing items from 5 subscales: physical well-being, social/family well-being, emotional well-being, functional well-being & lung cancer subscale. Score range: 0-136. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)Baseline106.09 score on a scale
Group I (MSM Intervention)Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)1 month post-discharge103.97 score on a scale
Group I (MSM Intervention)Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)3 months post-discharge103.54 score on a scale
Group II (Attention Control)Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)Baseline104.27 score on a scale
Group II (Attention Control)Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)1 month post-discharge99.17 score on a scale
Group II (Attention Control)Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)3 months post-discharge101.04 score on a scale
Primary

Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)

Mean caregiver preparedness scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in preparedness between the intervention and control arm over time. Score range: 0-4. Higher score means better outcome.

Time frame: Outcomes are measured before surgery (baseline), 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)Baseline2.55 score on a scale
Group I (MSM Intervention)Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)1 month post-discharge2.98 score on a scale
Group I (MSM Intervention)Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)3 months post-discharge2.94 score on a scale
Group II (Attention Control)Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)1 month post-discharge2.88 score on a scale
Group II (Attention Control)Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)Baseline2.60 score on a scale
Group II (Attention Control)Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)3 months post-discharge2.78 score on a scale
Primary

Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)

Differences in the number of caregivers who saw a support services specialist were compared between both groups using Chi-squared and Fisher's exact test.

Time frame: Outcomes are measured at discharge, 1 month, and 3 months post-discharge.

Population: Due to attrition in the study, the number of family caregivers assessed at discharge differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Group I (MSM Intervention)Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)Discharge8 Participants
Group I (MSM Intervention)Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)1 month post-discharge2 Participants
Group I (MSM Intervention)Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)3 months post-discharge0 Participants
Group II (Attention Control)Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)Discharge5 Participants
Group II (Attention Control)Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)1 month post-discharge0 Participants
Group II (Attention Control)Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)3 months post-discharge2 Participants
Primary

Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)

Differences in the number of patients who were readmitted to the hospital for an overnight stay were compared between both groups using Chi-squared and Fisher's exact test.

Time frame: Outcomes are measured at 1 month, and 3 months post-discharge.

Population: Due to attrition in the study, the number of patients assessed differed during follow-up timepoints.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Group I (MSM Intervention)Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)1 month post-discharge4 Participants
Group I (MSM Intervention)Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)3 months post-discharge7 Participants
Group II (Attention Control)Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)1 month post-discharge2 Participants
Group II (Attention Control)Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)3 months post-discharge8 Participants
Secondary

Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)

Mean caregiver activation scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in activation between the intervention and control arm over time. Score range: 10-60. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)Baseline46.33 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)1 month post-discharge48.50 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)3 months post-discharge47.79 score on a scale
Group II (Attention Control)Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)Baseline47.30 score on a scale
Group II (Attention Control)Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)1 month post-discharge48.76 score on a scale
Group II (Attention Control)Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)3 months post-discharge48.37 score on a scale
Secondary

Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)

Mean family caregiver knowledge scores from baseline to 3 months post-discharge were calculated. T-tests were used to assess differences in knowledge between the intervention and control arm at different timepoints. Score range: 0-10. Mean: 8.24 with a standard deviation of 1.19. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Group I (MSM Intervention)Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)Baseline8.00 T-scoreStandard Deviation 1.16
Group I (MSM Intervention)Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)1 month post-discharge8.76 T-scoreStandard Deviation 0.85
Group I (MSM Intervention)Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)3 months post-discharge8.69 T-scoreStandard Deviation 0.91
Group II (Attention Control)Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)3 months post-discharge8.15 T-scoreStandard Deviation 1.26
Group II (Attention Control)Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)Baseline7.64 T-scoreStandard Deviation 1.42
Group II (Attention Control)Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)1 month post-discharge8.45 T-scoreStandard Deviation 0.91
Secondary

Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)

Mean caregiver self-efficacy scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in self-efficacy between the intervention and control arm over time. Score range: 1-4. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)Baseline3.33 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)1 month post-discharge3.47 score on a scale
Group I (MSM Intervention)Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)3 months post-discharge3.52 score on a scale
Group II (Attention Control)Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)Baseline3.33 score on a scale
Group II (Attention Control)Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)1 month post-discharge3.38 score on a scale
Group II (Attention Control)Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)3 months post-discharge3.40 score on a scale
Secondary

Change in Patient Activation (as Measured by the Patient Activation Measure)

Mean patient activation scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in activation between the intervention and control arm over time. Score range: 0-100. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Patient Activation (as Measured by the Patient Activation Measure)Baseline73.30 score on a scale
Group I (MSM Intervention)Change in Patient Activation (as Measured by the Patient Activation Measure)1 month post-discharge75.41 score on a scale
Group I (MSM Intervention)Change in Patient Activation (as Measured by the Patient Activation Measure)3 months post-discharge74.47 score on a scale
Group II (Attention Control)Change in Patient Activation (as Measured by the Patient Activation Measure)Baseline71.51 score on a scale
Group II (Attention Control)Change in Patient Activation (as Measured by the Patient Activation Measure)1 month post-discharge71.00 score on a scale
Group II (Attention Control)Change in Patient Activation (as Measured by the Patient Activation Measure)3 months post-discharge72.38 score on a scale
Secondary

Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)

Mean patient knowledge scores from baseline to 3 months post-discharge were calculated. T-tests were used to assess differences in knowledge between the intervention and control arm at different timepoints. Score range: 0-10. Mean: 8.42 with a standard deviation of 1.16. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Group I (MSM Intervention)Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)Baseline7.98 T-scoreStandard Deviation 1.25
Group I (MSM Intervention)Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)1 month post-discharge9.00 T-scoreStandard Deviation 1.18
Group I (MSM Intervention)Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)3 months post-discharge8.82 T-scoreStandard Deviation 1
Group II (Attention Control)Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)Baseline7.98 T-scoreStandard Deviation 1.03
Group II (Attention Control)Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)1 month post-discharge8.48 T-scoreStandard Deviation 1.11
Group II (Attention Control)Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)3 months post-discharge8.50 T-scoreStandard Deviation 0.9
Secondary

Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)

Mean patient self-efficacy scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in self-efficacy between the intervention and control arm over time. Score range: 1-4. Higher score means better outcome.

Time frame: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

ArmMeasureGroupValue (MEAN)
Group I (MSM Intervention)Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)Baseline3.60 score on a scale
Group I (MSM Intervention)Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)1 month post-discharge3.60 score on a scale
Group I (MSM Intervention)Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)3 months post-discharge3.56 score on a scale
Group II (Attention Control)Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)Baseline3.51 score on a scale
Group II (Attention Control)Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)1 month post-discharge3.52 score on a scale
Group II (Attention Control)Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)3 months post-discharge3.55 score on a scale

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026